Project Number 1R41AG079778-01A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Developing Novel REV-ERB Agonists for the Treatment of Neuroinflammation in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator WILLIAMS, ROBERT Principal Investigator First Name ROBERT Principal Investigator Last Name WILLIAMS Awardee Organization PELAGOS PHARMACEUTICALS, INC. Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $449,482 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
